Literature DB >> 15197300

Characterization of endothelial internalization and targeting of antibody-enzyme conjugates in cell cultures and in laboratory animals.

Silvia Muro1, Vladimir R Muzykantov, Juan-Carlos Murciano.   

Abstract

Streptavidin-biotin conjugates of enzymes with carrier antibodies provide a versatile means for targeting selected cellular populations in cell cultures and in vivo. Both specific delivery to cells and proper subcellular addressing of enzyme cargoes are important parameters of targeting. This chapter describes methodologies for evaluating the binding and internalization of labeled conjugates directed to endothelial surface adhesion molecules in cell cultures using anti-intercellular adhesion molecule/catalase or antiplatelet endothelial cell adhesion molecule/catalase conjugates as examples. It also describes protocols for characterization of biodistribution and pulmonary targeting of radiolabeled conjugates in rats using anti-intercellular adhesion molecule/tPA conjugates as an example. The experimental procedures, results, and notes provided may help in investigations of vascular immunotargeting of reporter, experimental, diagnostic, or therapeutic enzymes to endothelial and, perhaps, other cell types, both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15197300     DOI: 10.1385/1-59259-813-7:021

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  18 in total

Review 1.  Endothelial nanomedicine for the treatment of pulmonary disease.

Authors:  Jacob S Brenner; Colin Greineder; Vladimir Shuvaev; Vladimir Muzykantov
Journal:  Expert Opin Drug Deliv       Date:  2014-11-14       Impact factor: 6.648

2.  PECAM-targeted delivery of SOD inhibits endothelial inflammatory response.

Authors:  Vladimir V Shuvaev; Jingyan Han; Kevin J Yu; Shaohui Huang; Brian J Hawkins; Muniswamy Madesh; Marian Nakada; Vladimir R Muzykantov
Journal:  FASEB J       Date:  2010-09-27       Impact factor: 5.191

3.  Altered Clathrin-Independent Endocytosis in Type A Niemann-Pick Disease Cells and Rescue by ICAM-1-Targeted Enzyme Delivery.

Authors:  Jeff Rappaport; Rachel L Manthe; Carmen Garnacho; Silvia Muro
Journal:  Mol Pharm       Date:  2015-04-23       Impact factor: 4.939

4.  Biodegradable "Smart" Polyphosphazenes with Intrinsic Multifunctionality as Intracellular Protein Delivery Vehicles.

Authors:  Andre P Martinez; Bareera Qamar; Thomas R Fuerst; Silvia Muro; Alexander K Andrianov
Journal:  Biomacromolecules       Date:  2017-05-30       Impact factor: 6.988

5.  Intra- and trans-cellular delivery of enzymes by direct conjugation with non-multivalent anti-ICAM molecules.

Authors:  Rasa Ghaffarian; Niksa Roki; Abraham Abouzeid; Wyatt Vreeland; Silvia Muro
Journal:  J Control Release       Date:  2016-07-27       Impact factor: 9.776

6.  Intertwined mechanisms define transport of anti-ICAM nanocarriers across the endothelium and brain delivery of a therapeutic enzyme.

Authors:  Rachel L Manthe; Maximilian Loeck; Tridib Bhowmick; Melani Solomon; Silvia Muro
Journal:  J Control Release       Date:  2020-05-07       Impact factor: 9.776

Review 7.  Dynamic factors controlling targeting nanocarriers to vascular endothelium.

Authors:  Vladimir R Muzykantov; Ravi Radhakrishnan; David M Eckmann
Journal:  Curr Drug Metab       Date:  2012-01       Impact factor: 3.731

8.  Spatially controlled assembly of affinity ligand and enzyme cargo enables targeting ferritin nanocarriers to caveolae.

Authors:  Vladimir V Shuvaev; Makan Khoshnejad; Katherine W Pulsipher; Raisa Yu Kiseleva; Evguenia Arguiri; Jasmina C Cheung-Lau; Kathleen M LeFort; Melpo Christofidou-Solomidou; Radu V Stan; Ivan J Dmochowski; Vladimir R Muzykantov
Journal:  Biomaterials       Date:  2018-09-12       Impact factor: 12.479

9.  Synthesis and characterization of polymer nanocarriers for the targeted delivery of therapeutic enzymes.

Authors:  Eric Simone; Thomas Dziubla; Vladimir Shuvaev; Vladimir R Muzykantov
Journal:  Methods Mol Biol       Date:  2010

Review 10.  Targeted delivery of therapeutics to endothelium.

Authors:  Eric Simone; Bi-Sen Ding; Vladimir Muzykantov
Journal:  Cell Tissue Res       Date:  2008-09-25       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.